Drug Shortage Report for M-PREGABALIN
Report ID | 147866 |
Drug Identification Number | 02467321 |
Brand name | M-PREGABALIN |
Common or Proper name | Pregabalin |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-10-12 |
Estimated end date | 2021-11-10 |
Actual end date | 2021-10-27 |
Shortage status | Resolved |
Updated date | 2021-10-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-10-29 | French | Compare |
v3 | 2021-10-29 | English | Compare |
v2 | 2021-10-22 | French | Compare |
v1 | 2021-10-22 | English | Compare |
Showing 1 to 4 of 4